10.6084/m9.figshare.5793861.v4
Gregory J. Feldman
Gregory J.
Feldman
Ana R. Sousa
Ana R.
Sousa
David A. Lipson
David
A. Lipson
Lee Tombs
Lee
Tombs
Neil Barnes
Neil
Barnes
John H. Riley
John
H. Riley
Sadhana Patel
Sadhana
Patel
Ian Naya
Ian
Naya
Chris Compton
Chris
Compton
Bernardino Alcázar Navarrete
Bernardino Alcázar
Navarrete
Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study
Adis Journals
2018
Bronchodilation
COPD
LAMA
LABA
Long-acting muscarinic antagonist
Long-acting β2-agonist
Olodaterol
Tiotropium
Umeclidinium
Vilanterol
2018-01-17 14:55:41
Dataset
https://adisjournals.figshare.com/articles/dataset/Comparative_Efficacy_of_Once-Daily_Umeclidinium_Vilanterol_and_Tiotropium_Olodaterol_Therapy_in_Symptomatic_Chronic_Obstructive_Pulmonary_Disease_A_Randomized_Study/5793861
<h2>Article full text</h2><p>The full text of this article can be found here <a href="https://link.springer.com/article/10.1007/s12325-017-0626-4">https://link.springer.com/article/10.1007/s12325-017-0626-4</a>.</p><h2>Provide enhanced content for this article</h2><p>If you are an author of this publication and would like to provide additional enhanced content for your article then please contact <a href="http://www.medengine.com/Redeem/âmailto:adisrapidplus@springer.comâ">adisrapidplus@springer.com</a>.</p><p>The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.</p><p>Other enhanced features include, but are not limited to:</p><ul><li>Summary slides</li><li>Slide decks</li><li>Videos and animations</li><li>Audio abstracts</li><li>Audio slides</li></ul>